A“one-two punch” that features a BRAF inhibitor plus a MEK inhibitor is an effective strategy to treat metastatic cutaneous melanoma,...

“Our findings suggest that omaveloxolone may overcome resistance to checkpoint inhibitors. Omaveloxolone in combination with checkpoint bloc